A carregar...
An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability
BACKGROUND: Ocrelizumab, an anti-CD20 humanized monoclonal antibody, reduced disease progression in pivotal trials of patients with relapsing (OPERA I, OPERA II) and primary progressive (ORATORIO) multiple sclerosis (MS). These effects may be particularly important among patients with increased disa...
Na minha lista:
| Publicado no: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7079307/ https://ncbi.nlm.nih.gov/pubmed/32206332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320911939 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|